Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Hancock

Showing results (51-60 of 190) with videos related to

Pageof 19
Sort By:
European Journal of Cancer & Clinical Oncology|July 1, 1985
An assessment of natural cell-mediated cytotoxicity in patients with malignant lymphomaF Healy, R C Rees, B W Hancock
Clinical Radiology|September 1, 1985
Extranodal lymphoma of the head and neck: a review of 49 consecutive casesM McGurk, J R Goepel, B W Hancock
Cancer Letters|January 15, 1993
High incidence of mutations of the p53 gene detected in ovarian tumours by the use of chemical mismatch cleavageE Sheridan, B W Hancock, M H Goyns
Journal of Clinical Pathology|November 1, 1982
Serum ferritin in normal individuals and in patients with malignant lymphoma and chronic renal failure measured with seven different commercial immunoassay techniquesA Grail, B W Hancock, P M Harrison
Lancet (London, England)|December 18, 1976
Height and Hodgkin's diseaseB W Hancock, R Mosely, A J Coup
International Journal of Oncology|May 5, 2005
Cutaneous CD56 positive natural killer and cytotoxic T-cell lymphomasA Chattopadhyay, D N Slater, B W Hancock
British Journal of Cancer|April 26, 2000
Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancyA M Gillespie, S Kumar, B W Hancock
British Journal of Haematology|April 1, 1994
Changes in the phenotypic characteristics of eosinophils from patients receiving recombinant human interleukin-2 (rhIL-2) therapyS Rodgers, R C Rees, B W Hancock
Gut|March 1, 1982
Herpesvirus colitis: a new cause of diarrhoea in a patient with Hodgkin's diseaseA J Boulton, D N Slater, B W Hancock
Cancer Immunology, Immunotherapy : CII|January 1, 1992
The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2C R Carter, B W Hancock, R C Rees
Pageof 19

Showing results (51-60 of 190) with videos related to

Sort By:
Pageof 19
European Journal of Cancer & Clinical Oncology|July 1, 1985
An assessment of natural cell-mediated cytotoxicity in patients with malignant lymphomaF Healy, R C Rees, B W Hancock
Clinical Radiology|September 1, 1985
Extranodal lymphoma of the head and neck: a review of 49 consecutive casesM McGurk, J R Goepel, B W Hancock
Cancer Letters|January 15, 1993
High incidence of mutations of the p53 gene detected in ovarian tumours by the use of chemical mismatch cleavageE Sheridan, B W Hancock, M H Goyns
Journal of Clinical Pathology|November 1, 1982
Serum ferritin in normal individuals and in patients with malignant lymphoma and chronic renal failure measured with seven different commercial immunoassay techniquesA Grail, B W Hancock, P M Harrison
Lancet (London, England)|December 18, 1976
Height and Hodgkin's diseaseB W Hancock, R Mosely, A J Coup
International Journal of Oncology|May 5, 2005
Cutaneous CD56 positive natural killer and cytotoxic T-cell lymphomasA Chattopadhyay, D N Slater, B W Hancock
British Journal of Cancer|April 26, 2000
Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancyA M Gillespie, S Kumar, B W Hancock
British Journal of Haematology|April 1, 1994
Changes in the phenotypic characteristics of eosinophils from patients receiving recombinant human interleukin-2 (rhIL-2) therapyS Rodgers, R C Rees, B W Hancock
Gut|March 1, 1982
Herpesvirus colitis: a new cause of diarrhoea in a patient with Hodgkin's diseaseA J Boulton, D N Slater, B W Hancock
Cancer Immunology, Immunotherapy : CII|January 1, 1992
The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2C R Carter, B W Hancock, R C Rees
Pageof 19